buspirone and Anxiety Neuroses studies

Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.

Research Excerpts

Excerpt	Relevance	Reference
" Buspirone, a non-benzodiazepine anxiolytic which does not suppress respiration and has proven efficacy in the treatment of generalized anxiety disorder, has been suggested to relieve the sensation of dyspnea in patients with COPD."	9.22	Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study. ( Banerjee, TK; Bushunow, PW; Dakhil, SR; Dudgeon, DJ; Flannery, MA; Garland, SN; Heckler, CE; Hopkins, JO; Kirshner, JJ; Morrow, GR; Peoples, AR; Peppone, LL; Roscoe, JA, 2016)
"Buspirone, a new anxiolytic agent, was used in a multiple-baseline, placebo lead-in study for the treatment of aggression and anxiety in six mentally retarded adult patients."	9.07	Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study. ( Parks, A; Ratey, J; Rogentine, K; Sovner, R, 1991)
"In a double-blind, crossover study, 13 fluoxetine-treated patients with obsessive-compulsive disorder were given adjuvant buspirone and placebo for 4 weeks each."	9.07	Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder. ( Bernstein, SE; Grady, TA; Hill, JL; L'Heureux, F; Murphy, DL; Pigott, TA, 1993)
"The authors found that buspirone added to the treatment of 33 patients with obsessive-compulsive disorder who were refractory to the serotonin reuptake inhibitor fluvoxamine was no better than placebo in reducing obsessive-compulsive, depressive, or anxiety symptoms."	9.07	Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder. ( Barr, LC; Goodman, WK; Heninger, GR; Holzer, JC; Leckman, JF; McCance-Katz, E; McDougle, CJ; Price, LH, 1993)
"Treatment with buspirone was safe and well-tolerated and resulted in sustained improvement in symptoms of anxiety for a minimum of 2 years in all 3 cases."	8.12	Buspirone for the Treatment of Generalized Anxiety Disorder in Down Syndrome: 3 Cases. ( Howe, YJ; McDougle, CJ; Notson, EE; Palumbo, ML; Thom, RP, 2022)
"We describe three patients who were given open-label buspirone for the treatment of behaviors thought to be related to anxiety."	7.91	Buspirone for the treatment of anxiety-related symptoms in Angelman syndrome: a case series. ( Balaj, K; Keary, CJ; McDougle, CJ; Mullett, J; Nowinski, L; Palumbo, ML; Thibert, RL; Walsh, B, 2019)
"Buspirone is a nonbenzodiazepine anxiolytic that has been effective in uncontrolled trials for treating childhood anxiety disorders."	7.69	Buspirone treatment of anxiety associated with pharyngeal dysphagia in a four-year-old. ( Albright, KJ; Feibusch, EL; Hanna, GL, 1997)
" A retrospective chart review was employed to examine the use of buspirone in treating anxiety in intravenous drug users with acquired immune deficiency syndrome (AIDS) or AIDS-related complex who were receiving methadone maintenance treatment."	7.68	Buspirone in drug users with AIDS or AIDS-related complex. ( Batki, SL, 1990)
"The author presents a case report of a 46-year-old man with generalized anxiety disorder and transvestic fetishism who responded to treatment with buspirone."	7.67	Buspirone hydrochloride in the treatment of transvestic fetishism. ( Fedoroff, JP, 1988)
"Buspirone HCl (Buspar) is a novel anxiolytic agent unrelated to the benzodiazepines or other psychotherapeutic agents."	6.65	Buspirone: an anxioselective alternative for the management of anxiety disorders. ( Eison, AS; Eison, MS; Newton, RE; Riblet, LA; Taylor, DP; Temple, DL, 1983)
" Comparisons between buspirone and the benzodiazepines in treating patients with generalised anxiety disorder reveal that long term use of benzodiazepines is associated with adverse effects, particularly in elderly patients."	6.40	A risk-benefit assessment of buspirone in the treatment of anxiety disorders. ( Pecknold, JC, 1997)
" Buspirone, a non-benzodiazepine anxiolytic which does not suppress respiration and has proven efficacy in the treatment of generalized anxiety disorder, has been suggested to relieve the sensation of dyspnea in patients with COPD."	5.22	Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study. ( Banerjee, TK; Bushunow, PW; Dakhil, SR; Dudgeon, DJ; Flannery, MA; Garland, SN; Heckler, CE; Hopkins, JO; Kirshner, JJ; Morrow, GR; Peoples, AR; Peppone, LL; Roscoe, JA, 2016)
" We investigated 51 dually diagnosed patients (generalized anxiety/alcohol abuse:dependence) in a randomized, double-blind, placebo-controlled trial of the serotonin partial agonist buspirone."	5.07	Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). ( Montague-Clouse, J; Tollefson, GD; Tollefson, SL, 1992)
"The present study is a double-blind control trial of buspirone versus placebo in highly anxious alcoholics who recently completed inpatient detoxification for alcoholism."	5.07	A placebo-controlled trial of buspirone in anxious inpatient alcoholics. ( Anton, RF; Brady, K; Johnston, A; Malcolm, R; Randall, CL; Thevos, A, 1992)
"Buspirone, a new anxiolytic agent, was used in a multiple-baseline, placebo lead-in study for the treatment of aggression and anxiety in six mentally retarded adult patients."	5.07	Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study. ( Parks, A; Ratey, J; Rogentine, K; Sovner, R, 1991)
" We investigated 51 dually diagnosed patients (generalized anxiety disorder with depressive features plus alcohol abuse/dependency) under a randomized, double-blind, placebo-controlled trial employing the 5-HT1A compound buspirone."	5.07	The association of buspirone and its metabolite 1-pyrimidinylpiperazine in the remission of comorbid anxiety with depressive features and alcohol dependency. ( Lancaster, SP; Montague-Clouse, J; Tollefson, GD, 1991)
"In a double-blind, crossover study, 13 fluoxetine-treated patients with obsessive-compulsive disorder were given adjuvant buspirone and placebo for 4 weeks each."	5.07	Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder. ( Bernstein, SE; Grady, TA; Hill, JL; L'Heureux, F; Murphy, DL; Pigott, TA, 1993)
"The authors found that buspirone added to the treatment of 33 patients with obsessive-compulsive disorder who were refractory to the serotonin reuptake inhibitor fluvoxamine was no better than placebo in reducing obsessive-compulsive, depressive, or anxiety symptoms."	5.07	Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder. ( Barr, LC; Goodman, WK; Heninger, GR; Holzer, JC; Leckman, JF; McCance-Katz, E; McDougle, CJ; Price, LH, 1993)
"This report presents results from an international multicenter trial of the safety of buspirone in the treatment of anxiety disorders for periods up to one year, if needed; 424 patients were treated for six months, and 264 patients completed a full year of treatment."	5.06	Long-term buspirone therapy for chronic anxiety: a multicenter international study to determine safety. ( Rakel, RE, 1990)
"Thirty-six patients with generalised anxiety disorder, panic disorder or agoraphobia with panic attacks, diagnosed by DSM-III criteria, were treated with a new non-benzodiazepine anti-anxiety drug, buspirone, and with diazepam and placebo, in a cross-over design."	5.05	Anxiety in primary care: is short-term drug treatment appropriate? ( Owen, R; Tyrer, P, 1984)
"The five published controlled studies on the effects of buspirone in alcoholism treatment are reviewed."	4.79	Efficacy of buspirone in alcohol dependence: a review. ( Dongier, M; Malec, EA; Malec, TS, 1996)
"The demonstrated efficacy in anxiety disorders of drugs such as buspirone or fluoxetine has emphasized the importance of 5-hydroxytryptamine (5-HT or serotonin)."	4.79	Serotonin receptor specificity in anxiety disorders. ( Lucki, I, 1996)
"A review of the worldwide published literature was conducted to assess the efficacy and safety of alprazolam for the treatment of anxiety disorders, panic disorder, and depression in comparison with those of other active drugs (including other benzodiazepines and antidepressant medications)."	4.78	A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature. ( Cohon, MS; Jonas, JM, 1993)
"Treatment with buspirone was safe and well-tolerated and resulted in sustained improvement in symptoms of anxiety for a minimum of 2 years in all 3 cases."	4.12	Buspirone for the Treatment of Generalized Anxiety Disorder in Down Syndrome: 3 Cases. ( Howe, YJ; McDougle, CJ; Notson, EE; Palumbo, ML; Thom, RP, 2022)
"We describe three patients who were given open-label buspirone for the treatment of behaviors thought to be related to anxiety."	3.91	Buspirone for the treatment of anxiety-related symptoms in Angelman syndrome: a case series. ( Balaj, K; Keary, CJ; McDougle, CJ; Mullett, J; Nowinski, L; Palumbo, ML; Thibert, RL; Walsh, B, 2019)
"Buspirone Hydrochloride is an anxiolytic agent and serotonin receptor agonist belonging to azaspirodecanedione class of compounds used in the treatment of anxiety disorders."	3.88	Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route. ( Dua, K; Gujar, KN; Madan, JR; Mathure, D; Ranpise, HA; Tupsamundre, A, 2018)
" Based on all available information, receiving antidepressant or buspirone medication for at least 2 months with at least four visits with any type of physician or at least eight sessions of psychotherapy within 12 months or at least 4 days of hospitalization were regarded as minimally adequate treatment for anxiety disorders."	3.83	Treatment adequacy of anxiety disorders among young adults in Finland. ( Aalto-Setälä, T; Kasteenpohja, T; Marttunen, M; Perälä, J; Saarni, SI; Suvisaari, J, 2016)
"The desire of the pharmaceutical industry to obtain more selective agents for the treatment of anxiety with fewer or diminished side effects and a profile consistent with safety during long-term use resulted in a search which has identified the azapirones as a new class of anxiolytics which lack structural or biochemical homology with the benzodiazepines."	3.77	Buspirone and related compounds as alternative anxiolytics. ( Moon, SL; Taylor, DP, 1991)
" This article reviews drug-drug interactions for an effective new non-benzodiazepine anxiolytic, buspirone."	3.76	Alcohol and drug interactions with antianxiety medications. ( Schuckit, MA, 1987)
"Buspirone is a nonbenzodiazepine anxiolytic that has been effective in uncontrolled trials for treating childhood anxiety disorders."	3.69	Buspirone treatment of anxiety associated with pharyngeal dysphagia in a four-year-old. ( Albright, KJ; Feibusch, EL; Hanna, GL, 1997)
" A retrospective chart review was employed to examine the use of buspirone in treating anxiety in intravenous drug users with acquired immune deficiency syndrome (AIDS) or AIDS-related complex who were receiving methadone maintenance treatment."	3.68	Buspirone in drug users with AIDS or AIDS-related complex. ( Batki, SL, 1990)
"Pooled data for 427 patients with generalized anxiety disorders were analyzed retrospectively from six double-blind trials evaluating buspirone, a nonbenzodiazepine anxiolytic, in the treatment of generalized anxiety disorder."	3.67	Analysis of individual symptoms in generalized anxiety--a pooled, multistudy, double-blind evaluation of buspirone. ( Cohn, JB; Feighner, JP, 1989)
"The author presents a case report of a 46-year-old man with generalized anxiety disorder and transvestic fetishism who responded to treatment with buspirone."	3.67	Buspirone hydrochloride in the treatment of transvestic fetishism. ( Fedoroff, JP, 1988)
" She was given 25 mg of intramuscular diphenhydramine and 1 mg of intramuscular benztropine mesylate, which resulted in little relief; however, 1 mg clonazepam caused both the myoclonic jerks and dystonias to resolve completely."	3.67	Acute generalized myoclonus following buspirone administration. ( Bridenbaugh, RH; Jabbari, B; Ritchie, EC, 1988)
" Data were derived from an earlier study, designed to compare efficacy and tolerability of fixed dosage of extended-release venlafaxine, mitazapine, paroxetine, and risperidone, sodium valproate, buspirone, trazodone or thyroid hormone augmenting to paroxetine in those patients."	2.78	Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study. ( Cao, L; Chen, J; Fang, Y; Hong, W; Peng, D; Wu, Z; Yuan, C; Zhang, C, 2013)
"Buspirone was generally safe and well tolerated at doses up to 30 mg bid in adolescents and adults and most of the children."	2.70	Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adults. ( Cutler, NR; Dockens, R; Frackiewicz, EJ; Fulmor, IE; Kollia, G; Salazar, DE; Shiovitz, TM; Sramek, JJ; Tigel, PD; Uderman, HD, 2001)
"Sixty patients with GAD were randomly assigned to treatment with buspirone or placebo, combined with anxiety management training or non-directive therapy for a period of 8 weeks."	2.70	Treatment of generalised anxiety disorder with a short course of psychological therapy, combined with buspirone or placebo. ( Bond, AJ; Lader, MH; Valerie Curran, H; Wingrove, J, 2002)
"Both buspirone and lorazepam were more efficacious in reducing anxiety symptoms than placebo during the treatment and taper period; however, in contrast to the active drugs (buspirone, lorazepam), patients of the placebo group showed further clinical improvement during the control period, especially in the HAM-A score, so differences between placebo and active drugs became smaller at the end of the study."	2.69	Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients. ( Baghai, T; Ehrentraut, S; Kuhn, K; Laakmann, G; Lorkowski, G; Schüle, C, 1998)
" The adverse events were not essentially different between treatment groups."	2.69	Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. ( Davidson, JR; DuPont, RL; Haskins, JT; Hedges, D, 1999)
"Buspirone-treated patients showed no rebound anxiety or benzodiazepine-withdrawal syndrome compared with placebo."	2.68	Assessment of the efficacy of buspirone in patients affected by generalized anxiety disorder, shifting to buspirone from prior treatment with lorazepam: a placebo-controlled, double-blind study. ( Casacchia, M; Delle Chiaie, R; Kotzalidis, GD; Pancheri, P; Stratta, P; Zibellini, M, 1995)
"Buspirone was associated with a slower onset of action and better symptom relief than placebo after 6 weeks of therapy."	2.68	Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone. ( Manfro, GG; Otto, MW; Pollack, MH; Worthington, JJ; Zucker, BG, 1997)
"Buspirone-treated patients averaged a 12."	2.68	Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms. ( Amsterdam, JD; Cutler, NR; Hornig-Rohan, M; Sramek, JJ; Stahl, SM; Suri, A; Tansman, M; Weisler, RH, 1996)
"Buspirone was not an effective treatment."	2.67	The assessment and treatment of performance anxiety in musicians. ( Agras, WS; Clark, DB, 1991)
"Buspirone therapy was associated with greater retention in the 12-week treatment trial, reduced anxiety, a slower return to heavy alcohol consumption, and fewer drinking days during the follow-up period."	2.67	Buspirone treatment of anxious alcoholics. A placebo-controlled trial. ( Babor, TF; Bohn, MJ; Brown, J; Burleson, JA; Del Boca, FK; Korner, P; Kranzler, HR, 1994)
"Both buspirone and diazepam were equally effective in reducing overall anxiety symptoms."	2.67	Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients. ( van Laar, MW; van Willigenburg, AP; Volkerts, ER, 1992)
"Alprazolam-treated patients most frequently reported central nervous system-related side effects (drowsiness and sedation), while buspirone-treated patients most frequently reported gastrointestinal system-related side effects (appetite disturbances and abdominal complaints)."	2.67	Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder. ( Enkelmann, R, 1991)
"Buspirone was found to be safe and well tolerated at doses of up to 90 mg/day."	2.67	Buspirone in major depression: a controlled study. ( Amsterdam, JD; Clary, C; Puzzuoli, G; Rickels, K; Schweizer, E, 1991)
"One buspirone-treated and two placebo-treated patients discontinued treatment after 2 weeks because of lack of efficacy."	2.67	Buspirone therapy in anxious elderly patients: a controlled clinical trial. ( Alms, DR; Böhm, C; Gammans, RE; Leroy, A; Placchi, M; Robinson, DS; Shrotriya, RC, 1990)
"Buspirone was found to be safe and well-tolerated by patients with major depression and concomitant anxiety at doses of up to 90 mg/day."	2.67	Buspirone in depressed outpatients: a controlled study. ( Amsterdam, J; Clary, C; Hassman, J; London, J; Puzzuoli, G; Rickels, K; Schweizer, E, 1990)
"Buspirone was compared with imipramine and placebo in the treatment of panic disorder in an 8-week, double-blind controlled study of 52 randomly assigned patients."	2.67	Is buspirone effective for panic disorder? ( Raj, AB; Sheehan, DV; Sheehan, KH; Soto, S, 1990)
"Buspirone was compared to alprazolam and lorazepam in the treatment of generalized anxiety disorder in a 4-week, double-blind study of 60 patients."	2.66	Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study. ( Cohn, JB; Wilcox, CS, 1986)
"Buspirone and diazepam were equally effective in reducing Hamilton Anxiety (HAM-A) total and psychic factor scores from baseline values."	2.66	Evaluation of buspirone as an antianxiety agent: buspirone and diazepam versus placebo. ( Howarth, BG; Matas, M; Pecknold, JC; Ross, C; Swinson, R; Ungar, W; Vezeau, C, 1989)
"Buspirone is an antianxiety compound that has been extensively evaluated in clinical trials: it has proved superior to placebo and comparable to diazepam in the treatment of patients with generalized anxiety disorder."	2.66	A comparison of buspirone, diazepam, and placebo in patients with chronic anxiety states. ( Lader, M; Olajide, D, 1987)
"Imipramine was superior to placebo on many of the outcome measures."	2.66	The relative efficacy of buspirone, imipramine and placebo in panic disorder: a preliminary report. ( Raj, AB; Sheehan, DV; Sheehan, KH; Soto, S, 1988)
"Buspirone HCl (Buspar) is a novel anxiolytic agent unrelated to the benzodiazepines or other psychotherapeutic agents."	2.65	Buspirone: an anxioselective alternative for the management of anxiety disorders. ( Eison, AS; Eison, MS; Newton, RE; Riblet, LA; Taylor, DP; Temple, DL, 1983)
"Buspirone was given to 43 patients, diazepam to 46 and placebo to 42."	2.65	Buspirone: multicenter efficacy study. ( Wheatley, D, 1982)
"Future research strategies for new drug treatments in epilepsy will probably take comorbidities into account."	2.58	Pharmacological treatment of anxiety disorders in adults with epilepsy. ( Mula, M, 2018)
"Buspirone was evaluated in one flexibly dosed (N = 227) and one fixed-dose (N = 341) trial in children and adolescents aged 6-17 years with a primary diagnosis of GAD."	2.58	Buspirone in Children and Adolescents with Anxiety: A Review and Bayesian Analysis of Abandoned Randomized Controlled Trials. ( Cornwall, GJ; Croarkin, PE; Keeshin, BR; Mills, JA; Mossman, SA; Strawn, JR; Varney, ST, 2018)
"Studies of buspirone for substance use disorders have had disappointing outcomes, although it may be useful for treating coexisting anxiety and one controlled study suggested efficacy for heroin detoxification."	2.52	Buspirone: Back to the Future. ( Howland, RH, 2015)
"Hydroxyzine is an anti-histamine medication which has been used in the treatment of anxiety."	2.46	Hydroxyzine for generalised anxiety disorder. ( Barbui, C; Cipriani, A; Guaiana, G, 2010)
" Selective serotonin and serotonin-noradrenaline re-uptake inhibitors have become more viable treatments for GAD than the traditionally used benzodiazepines due to greater efficacy and a more tolerable adverse event profile."	2.42	The safety of SSRIs in generalised anxiety disorder: any reason to be anxious? ( Gupta, S; Masand, PS, 2003)
"Paroxetine is a selective serotonin re-uptake inhibitor useful in the treatment of a wide range of psychiatric disorders."	2.42	Paroxetine in the treatment of generalised anxiety disorder. ( Bellew, K; Rickels, K; Rynn, MA; Snyderman, SH, 2004)
"Buspirone has demonstrated anxiolytic benefits but, like benzodiazepines, shows negligible antidepressant action."	2.42	Treating generalized anxiety disorder. ( Gorman, JM, 2003)
"Buspirone was the first available alternative to the benzodiazepines in the US; however, the initial excitement over this agent was somewhat dampened because of its mild efficacy combined with a slow onset of action."	2.41	Generalised anxiety disorder: treatment options. ( Cutler, NR; Sramek, JJ; Zarotsky, V, 2002)
" While their association with sexual dysfunction may be intolerable for some adults, these drugs may be more appropriate than the benzodiazepines because their chronic use does not lead to dependence."	2.41	Pharmacotherapy of generalized anxiety disorder. ( Rickels, K; Rynn, M, 2002)
"Lifetime psychiatric illness is also common in women with PMDD, and although mood disorders predominate, past histories of anxiety disorders are also common, further suggesting an association between PMDD and anxiety disorders."	2.40	Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders? ( Yonkers, KA, 1997)
" Comparisons between buspirone and the benzodiazepines in treating patients with generalised anxiety disorder reveal that long term use of benzodiazepines is associated with adverse effects, particularly in elderly patients."	2.40	A risk-benefit assessment of buspirone in the treatment of anxiety disorders. ( Pecknold, JC, 1997)
"Buspirone is an azapirone with 5-HT1A partial agonist activity which has demonstrated efficacy in the treatment of generalized anxiety disorder, commonly referred to as persistent anxiety."	2.40	Meta-analysis of the safety and tolerability of two dose regimens of buspirone in patients with persistent anxiety. ( Cutler, NR; Hamid, S; Hong, WW; Nape, B; Sramek, JJ, 1999)
" Dosing instructions for buspirone and guidelines for switching patients from benzodiazepines to buspirone are offered."	2.40	Strategies for treatment of generalized anxiety in the primary care setting. ( Rickels, K; Schweizer, E, 1997)
"Buspirone has demonstrated some efficacy in the treatment of a broad range of other serotonin-related disorders."	2.39	Azapirones: an alternative to benzodiazepines for anxiety. ( Cadieux, RJ, 1996)
"Buspirone is a newer anxiolytic which differs chemically and pharmacologically from the benzodiazepines."	2.38	Can buspirone induce rebound, dependence or abuse? ( Lader, M, 1991)
"Anxiety disorders are chronic illnesses requiring long-term treatment."	2.38	Chronic anxiety: deciding the length of treatment. ( Gorman, JM; Papp, LA, 1990)
"Buspirone was the first novel drug to emerge from this search in almost thirty years."	2.38	Serotonin agents in anxiety. ( Taylor, DP, 1990)
" The effects of intoxication, withdrawal, and chronic use on anxiety and need to be taken into account and the primary vs."	2.38	The treatment of anxiety in patients with alcoholism. ( Borg, L; Frances, RJ, 1993)
"Buspirone is an anxiolytic drug from the azapirone family of molecules."	2.38	Buspirone: a worldwide update. ( Domantay, AG; Napoliello, MJ, 1991)
"Buspirone was not removed by hemodialysis."	2.37	Metabolism and disposition of buspirone. ( Gammans, RE; LaBudde, JA; Mayol, RF, 1986)
"Treatment with buspirone was well-tolerated and resulted in sustained response in all three cases."	1.56	Buspirone for the Treatment of Generalized Anxiety Disorder in Williams Syndrome: A Case Series. ( Keary, CJ; McDougle, CJ; Pober, BR; Thom, RP; Waxler, JL, 2020)
"Pretreatment with buspirone (1."	1.33	Buspirone attenuates conditioned fear-induced c-Fos expression in the rat hippocampus. ( Bidziński, A; Lehner, M; Maciejak, P; Płaźnik, A; Skórzewska, A; Szyndler, J; Taracha, E; Wisłowska-Stanek, A; Zienowicz, M, 2005)
" Further, the side effect profile in the elderly differed little from that in the younger patients."	1.27	The safety and usefulness of buspirone as an anxiolytic drug in elderly versus young patients. ( Napoliello, MJ; Robinson, D; Schenk, J, 1988)

Timeframe	Studies, this research(%)	All Research%
pre-1990	73 (30.29)	18.7374
1990's	97 (40.25)	18.2507
2000's	42 (17.43)	29.6817
2010's	25 (10.37)	24.3611
2020's	4 (1.66)	2.80

Trial	Phase	Enrollment	Study Type	Start Date	Status
Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety[NCT00177008]	Phase 4	18 participants	Interventional	2004-03-31	Completed
The Difference in Pharmacodynamic and Pharmacokinetic Profiles Between Tentin and Magisterial Dexamfetamine in Adults With Attention Deficit Hyperactivity Disorder, a Double Blinded Randomised Crossover-controlled Trial[NCT05621174]		26 participants (Anticipated)	Interventional	2023-04-14	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Article	Year
Buspirone in Children and Adolescents with Anxiety: A Review and Bayesian Analysis of Abandoned Randomized Controlled Trials. Journal of child and adolescent psychopharmacology, 2018, Volume: 28, Issue:1 Topics: Adolescent; Anti-Anxiety Agents; Anxiety Disorders; Bayes Theorem; Buspirone; Child; Humans; Patient	2018
Pharmacological treatment of anxiety disorders in adults with epilepsy. Expert opinion on pharmacotherapy, 2018, Volume: 19, Issue:17 Topics: Adult; Animals; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Epilepsy; Humans; Phobia, Social;	2018
[Clinical potential and possibilities of using buspirone in the treatment of anxiety disorders]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2014, Volume: 114, Issue:8 Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Comorbidity; Humans; Panic Disorder; Phobic Disor	2014
Pharmacotherapy for anxiety and comorbid alcohol use disorders. The Cochrane database of systematic reviews, 2015, Jan-20, Volume: 1 Topics: Alcohol-Related Disorders; Anxiety; Anxiety Disorders; Buspirone; Comorbidity; Desipramine; Humans;	2015
Buspirone: Back to the Future. Journal of psychosocial nursing and mental health services, 2015, Volume: 53, Issue:11 Topics: Aggression; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Cognition Disorders; Dementia; Depres	2015
Refractory generalized anxiety disorder. The Journal of clinical psychiatry, 2009, Volume: 70 Suppl 2 Topics: Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Anxiet	2009
The pharmacologic treatment of anxiety disorders: a review of progress. The Journal of clinical psychiatry, 2010, Volume: 71, Issue:7 Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Benzodiazepines; Bu	2010
Hydroxyzine for generalised anxiety disorder. The Cochrane database of systematic reviews, 2010, Dec-08, Issue:12 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Chlordiaz	2010
Pharmacological treatment of generalized anxiety disorder. Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:16 Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Central Nervous System Agents; H	2011
Generalised anxiety disorder. BMJ clinical evidence, 2011, Oct-27, Volume: 2011 Topics: Anxiety Disorders; Benzodiazepines; Buspirone; Humans; Hydroxyzine; Psychiatric Status Rating Scales	2011
Generalised anxiety disorder: treatment options. Drugs, 2002, Volume: 62, Issue:11 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical	2002
Pharmacotherapy of generalized anxiety disorder. The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 14 Topics: Algorithms; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders;	2002
Treating generalized anxiety disorder. The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 2 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzo	2003
The safety of SSRIs in generalised anxiety disorder: any reason to be anxious? Expert opinion on drug safety, 2003, Volume: 2, Issue:5 Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Cyclohexan	2003
Generalised anxiety disorder. Clinical evidence, 2003, Issue:9 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Carboline	2003
Paroxetine in the treatment of generalised anxiety disorder. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:8 Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anx	2004
Selecting pharmacotherapy for generalized anxiety disorder. The Journal of clinical psychiatry, 2004, Volume: 65 Suppl 13 Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Histamine H1 Antagonists; Humans	2004
Generalised anxiety disorder. Clinical evidence, 2004, Issue:11 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Carboline	2004
Generalised anxiety disorder. Clinical evidence, 2004, Issue:12 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Cognitive	2004
Comorbid anxiety and depression. The Journal of clinical psychiatry, 2005, Volume: 66 Suppl 8 Topics: Anticonvulsants; Antidepressive Agents; Anxiety Disorders; Buspirone; Cognitive Behavioral Therapy;	2005
Hyper-anxiety in early sobriety: psychopharmacological treatment strategies. Journal of psychosocial nursing and mental health services, 2006, Volume: 44, Issue:1 Topics: Alcohol-Related Disorders; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiaze	2006
Generalised anxiety disorder. Clinical evidence, 2005, Issue:14 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Carboline	2005
Azapirones for generalized anxiety disorder. The Cochrane database of systematic reviews, 2006, Jul-19, Issue:3 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Humans; P	2006
Anxiolytic profiles. The Journal of clinical psychiatry, 1983, Volume: 44, Issue:11 Pt 2 Topics: Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Behavior; Behavior, Animal; Benzodiazepine	1983
Anxiety in elderly patients. A comparison of azapirones and benzodiazepines. Drugs & aging, 1994, Volume: 5, Issue:5 Topics: Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Geriatric Assessment; Humans	1994
A combined treatment approach to anxiety in the medically ill. The Journal of clinical psychiatry, 1995, Volume: 56 Suppl 2 Topics: Aged; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Attitude to Health; Benzodiazep	1995
Psychopharmacology in HIV spectrum disorders. The Psychiatric clinics of North America, 1994, Volume: 17, Issue:1 Topics: Acquired Immunodeficiency Syndrome; AIDS Dementia Complex; Anti-Anxiety Agents; Antipsychotic Agents	1994
[Buspirone: a new possibility in the treatment of anxiety]. Orvosi hetilap, 1994, Aug-14, Volume: 135, Issue:33 Topics: Anxiety Disorders; Buspirone; Humans; Serotonin Receptor Agonists	1994
The treatment of generalized anxiety disorder in patients with depressive symptomatology. The Journal of clinical psychiatry, 1993, Volume: 54 Suppl Topics: Antidepressive Agents, Tricyclic; Antipsychotic Agents; Anxiety Disorders; Benzodiazepines; Buspiron	1993
Psychopharmacologic treatment of anxiety in the medically ill elderly patient: special considerations. The Journal of clinical psychiatry, 1993, Volume: 54 Suppl Topics: Age Factors; Aged; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Buspirone; Comorbi	1993
Treating anxiety while minimizing abuse and dependence. The Journal of clinical psychiatry, 1993, Volume: 54 Suppl Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clorazepate Dipotass	1993
Psychopharmacologic treatment of anxiety disorders in adolescents and children. The Journal of clinical psychiatry, 1993, Volume: 54 Suppl Topics: Adolescent; Age Factors; Anti-Anxiety Agents; Anxiety Disorders; Anxiety, Separation; Buspirone; Chi	1993
How to manage anxious patients who are depressed. The Journal of clinical psychiatry, 1993, Volume: 54 Suppl Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Depressiv	1993
A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature. The Journal of clinical psychiatry, 1993, Volume: 54 Suppl Topics: Alprazolam; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as	1993
The treatment of anxiety in patients with alcoholism. The Journal of clinical psychiatry, 1993, Volume: 54 Suppl Topics: Alcoholism; Anxiety Disorders; Benzodiazepines; Buspirone; Combined Modality Therapy; Comorbidity; D	1993
Azapirones: an alternative to benzodiazepines for anxiety. American family physician, 1996, May-15, Volume: 53, Issue:7 Topics: Aged; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Drug Monitoring; Humans; P	1996
Serotonin receptor specificity in anxiety disorders. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 6 Topics: Anxiety Disorders; Buspirone; Fluoxetine; Humans; Receptors, Serotonin; Selective Serotonin Reuptake	1996
Evaluation and treatment of anxiety symptoms and disorders in alcoholics. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 7 Topics: Alcohol Drinking; Alcoholism; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Buspirone; Clinical T	1996
Overview of generalized anxiety disorder in the elderly. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 7 Topics: Adolescent; Adult; Age Factors; Age of Onset; Aged; Anti-Anxiety Agents; Antipsychotic Agents; Anxie	1996
Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 7 Topics: Aged; Aggression; Antipsychotic Agents; Anxiety Disorders; Behavior Therapy; Buspirone; Carbamazepin	1996
Epidemiology and psychopharmacology of anxiety in medical patients. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 7 Topics: Adrenergic beta-Antagonists; Aged; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents;	1996
The long-term management of generalized anxiety disorder: issues and dilemmas. The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 7 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical	1996
Efficacy of buspirone in alcohol dependence: a review. Alcoholism, clinical and experimental research, 1996, Volume: 20, Issue:5 Topics: Alcoholism; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Comorbidity	1996
A risk-benefit assessment of buspirone in the treatment of anxiety disorders. Drug safety, 1997, Volume: 16, Issue:2 Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Humans; Substance Withdrawal Syn	1997
Strategies for treatment of generalized anxiety in the primary care setting. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 3 Topics: Anxiety Disorders; Benzodiazepines; Buspirone; Cognitive Behavioral Therapy; Combined Modality Thera	1997
Recognizing and treating anxiety in the elderly. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 3 Topics: Age Factors; Age of Onset; Aged; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone;	1997
Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders? The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 3 Topics: 1-Naphthylamine; Adult; Age of Onset; Anxiety; Anxiety Disorders; Buspirone; Carbon Dioxide; Comorbi	1997
A treatment algorithm for the management of anxiety in primary care practice. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 3 Topics: Algorithms; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Decision Trees; He	1997
Interaction of pharmacological and psychological treatments of anxiety. The British journal of psychiatry. Supplement, 1998, Issue:34 Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Combined Modality Therapy; Double-Blind Me	1998
Buspirone: future directions. Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:1 Topics: Anti-Anxiety Agents; Anxiety Disorders; Behavioral Symptoms; Buspirone; Forecasting; Humans; Selecti	1999
Meta-analysis of the safety and tolerability of two dose regimens of buspirone in patients with persistent anxiety. Depression and anxiety, 1999, Volume: 9, Issue:3 Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Double-Blind Method; Dr	1999
The functional anatomy, neurochemistry, and pharmacology of anxiety. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 22 Topics: Adrenergic Uptake Inhibitors; Amygdala; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clomipram	1999
Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder. The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 22 Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Buspirone; Clinical Tr	1999
Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinica	2000
Anxiety disorder. BMJ (Clinical research ed.), 2000, Nov-11, Volume: 321, Issue:7270 Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxie	2000
Pharmacotherapy of generalized anxiety disorder. The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 11 Topics: Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Ben	2001
Contemporary management of comorbid anxiety and depression in geriatric patients. The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 12 Topics: Age Factors; Aged; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Buspirone; Comorbi	2001
Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder. The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 19 Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Cyclohexanols; Drug	2001
Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:11 Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Cyclohexanols; Delayed-Action Preparations; Drug	2001
Treatment of generalized anxiety disorder. The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 8 Topics: Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Ben	2002
Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms. A meta-analysis of eight randomized, controlled studies. Neuropsychobiology, 1992, Volume: 25, Issue:4 Topics: Adolescent; Adult; Aged; Anxiety Disorders; Arousal; Buspirone; Depressive Disorder; Female; Humans;	1992
Buspirone and related compounds as alternative anxiolytics. Neuropeptides, 1991, Volume: 19 Suppl Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Binding Sites; Buspirone; Humans;	1991
Buspirone: a worldwide update. The British journal of psychiatry. Supplement, 1991, Issue:12 Topics: Anxiety Disorders; Buspirone; Depressive Disorder; Humans; Product Surveillance, Postmarketing	1991
Anxiety and alcoholism: a serotonin link. The British journal of psychiatry. Supplement, 1991, Issue:12 Topics: Alcoholism; Animals; Anxiety Disorders; Brain; Buspirone; Disease Models, Animal; Humans; Personalit	1991
Can buspirone induce rebound, dependence or abuse? The British journal of psychiatry. Supplement, 1991, Issue:12 Topics: Anxiety Disorders; Buspirone; Humans; Risk Factors; Substance-Related Disorders	1991
Generalized anxiety disorder: new concepts and psychopharmacologic therapies. The Journal of clinical psychiatry, 1990, Volume: 51 Suppl Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Humans; Psychotherapy; Receptors	1990
Chronic anxiety: deciding the length of treatment. The Journal of clinical psychiatry, 1990, Volume: 51 Suppl Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Chronic Disease; Drug Administra	1990
The clinical course and long-term management of generalized anxiety disorder. Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:3 Suppl Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Chronic Disease; Follow-Up Studi	1990
Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone. The Journal of clinical psychiatry, 1990, Volume: 51 Suppl Topics: Ambulatory Care; Anxiety Disorders; Buspirone; Double-Blind Method; Female; Humans; Lorazepam; Male;	1990
Buspirone in clinical practice. The Journal of clinical psychiatry, 1990, Volume: 51 Suppl Topics: Anxiety Disorders; Buspirone; Depressive Disorder; Female; Humans; Premenstrual Syndrome	1990
Treatment of anxiety disorder in patients with mood disorders. The Journal of clinical psychiatry, 1990, Volume: 51 Suppl Topics: Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Depressive Disorder; Humans; L	1990
Serotonin agents in anxiety. Annals of the New York Academy of Sciences, 1990, Volume: 600 Topics: Antidepressive Agents; Anxiety Disorders; Buspirone; Diazepam; Humans; Serotonin	1990
The new generation of serotonergic anxiolytics: possible clinical roles. Psychopathology, 1989, Volume: 22 Suppl 1 Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Arousal; Brain; Buspirone; Humans; Receptors, Serot	1989
Serotonin-1A anxiolytics: an overview. Psychopathology, 1989, Volume: 22 Suppl 1 Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Buspirone; Clinical Trials as Topic; Double-	1989
A pooled, double-blind comparison of the effects of buspirone, diazepam and placebo in women with chronic anxiety. Current medical research and opinion, 1989, Volume: 11, Issue:5 Topics: Adolescent; Adult; Aged; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Diazepam; Double-Bl	1989
[Pathogenesis of panic disorders]. Nederlands tijdschrift voor geneeskunde, 1989, Mar-11, Volume: 133, Issue:10 Topics: Adolescent; Adult; Anxiety Disorders; Buspirone; Fear; Female; Humans; Imipramine; Male; Panic	1989
Buspirone, a new approach to the treatment of anxiety. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 1988, Volume: 2, Issue:9 Topics: Anxiety Disorders; Buspirone; Chemical Phenomena; Chemistry; Humans; Receptors, GABA-A; Serotonin	1988
Biology of anxiety. The Medical clinics of North America, 1988, Volume: 72, Issue:4 Topics: Agoraphobia; Anxiety Disorders; Buspirone; Fear; Humans; Panic; Phobic Disorders; Receptors, GABA-A	1988
Generalized anxiety disorder. The Psychiatric clinics of North America, 1985, Volume: 8, Issue:1 Topics: Adrenergic beta-Antagonists; Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyc	1985
Review of the side-effect profile of buspirone. The American journal of medicine, 1986, Mar-31, Volume: 80, Issue:3B Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as T	1986
Alcohol and drug interactions with antianxiety medications. The American journal of medicine, 1987, May-22, Volume: 82, Issue:5A Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Drug I	1987
Long-term anxiolytic therapy: the issue of drug withdrawal. The Journal of clinical psychiatry, 1987, Volume: 48 Suppl Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Drug Tolerance; Humans; Substanc	1987
Antianxiety therapy: potential value of long-term treatment. The Journal of clinical psychiatry, 1987, Volume: 48 Suppl Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Chronic Disease; Counseling; Hum	1987
Assessing the potential for buspirone dependence or abuse and effects of its withdrawal. The American journal of medicine, 1987, May-22, Volume: 82, Issue:5A Topics: Animals; Anxiety Disorders; Buspirone; Humans; Pyrimidines; Risk; Substance Withdrawal Syndrome; Sub	1987
Buspirone in the long-term treatment of generalized anxiety disorder. The Journal of clinical psychiatry, 1987, Volume: 48 Suppl Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anxiety Disorders; Buspirone; Clinical Trials as Topic;	1987
Metabolism and disposition of buspirone. The American journal of medicine, 1986, Mar-31, Volume: 80, Issue:3B Topics: Absorption; Administration, Oral; Adolescent; Adult; Aged; Aging; Amitriptyline; Animals; Anxiety Di	1986

Article	Year
Human anxiety-specific "theta" occurs with selective stopping and localizes to right inferior frontal gyrus. Behavioral neuroscience, 2020, Volume: 134, Issue:6 Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Biomarkers; Buspirone; Electroencephalogr	2020
Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study. Journal of affective disorders, 2013, Sep-25, Volume: 150, Issue:3 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Buspirone; China; Comorbidity; Cy	2013
Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:3 Topics: Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Buspirone; Disease Management; Double-Blind Method;	2016
Randomized, single-blind, trial of sertraline and buspirone for treatment of elderly patients with generalized anxiety disorder. Psychiatry and clinical neurosciences, 2010, Volume: 64, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Diagnostic and Statistic	2010
Treatment of generalised anxiety disorder with a short course of psychological therapy, combined with buspirone or placebo. Journal of affective disorders, 2002, Volume: 72, Issue:3 Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Cognitive Behavioral The	2002
Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2003, Volume: 10 Suppl 4 Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Double-Blind Method; Drug Administra	2003
The effect of social factors on the anxiolytic efficacy of buspirone in male rats, male mice, and men. Progress in neuro-psychopharmacology & biological psychiatry, 2003, Volume: 27, Issue:8 Topics: Aged; Aged, 80 and over; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety Disorders; Busp	2003
Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study. Headache, 2005, Volume: 45, Issue:8 Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Double-Blind Method; Female; Humans; Male;	2005
Recent advances in anxiolytic therapy. The Journal of clinical psychiatry, 1981, Volume: 42, Issue:11 Pt 2 Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Tria	1981
The side effect profile of buspirone in comparison to active controls and placebo. The Journal of clinical psychiatry, 1982, Volume: 43, Issue:12 Pt 2 Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Clorazepate Dipotassium	1982
A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder. The Journal of clinical psychiatry, 1982, Volume: 43, Issue:12 Pt 2 Topics: Adolescent; Adult; Ambulatory Care; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clinical Tria	1982
"Buspirone: a clinical review of a new, non-benzodiazepine anxiolytic". The Journal of clinical psychiatry, 1982, Volume: 43, Issue:12 Pt 2 Topics: Anti-Anxiety Agents; Anxiety Disorders; Arousal; Buspirone; Clinical Trials as Topic; Cost-Benefit A	1982
Buspirone and diazepam in anxiety: a controlled study. The Journal of clinical psychiatry, 1982, Volume: 43, Issue:12 Pt 2 Topics: Adult; Ambulatory Care; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clinical Trials as Topic;	1982
Buspirone: multicenter efficacy study. The Journal of clinical psychiatry, 1982, Volume: 43, Issue:12 Pt 2 Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Diazepam;	1982
Drug interactions in controlled clinical trials. The Journal of clinical psychiatry, 1982, Volume: 43, Issue:12 Pt 2 Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Clorazepate Dipotassium	1982
Nonbenzodiazepine anxiolytics: clinical usefulness. The Journal of clinical psychiatry, 1983, Volume: 44, Issue:11 Pt 2 Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Ag	1983
Buspirone: an anxioselective alternative for the management of anxiety disorders. Progress in neuro-psychopharmacology & biological psychiatry, 1983, Volume: 7, Issue:4-6 Topics: Aggression; Animals; Anxiety Disorders; Arousal; Avoidance Learning; Buspirone; Clinical Trials as T	1983
Anxiety in primary care: is short-term drug treatment appropriate? Journal of psychiatric research, 1984, Volume: 18, Issue:1 Topics: Adult; Agoraphobia; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Diazepam; Female; Humans	1984
Comparison of buspirone in two separate studies. The Journal of clinical psychiatry, 1982, Volume: 43, Issue:12 Pt 2 Topics: Adult; Ambulatory Care; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Clorazepate Dipotass	1982
Assessment of the efficacy of buspirone in patients affected by generalized anxiety disorder, shifting to buspirone from prior treatment with lorazepam: a placebo-controlled, double-blind study. Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:1 Topics: Adult; Anxiety Disorders; Buspirone; Double-Blind Method; Female; Humans; Lorazepam; Male; Middle Ag	1995
Buspirone treatment of anxious alcoholics. A placebo-controlled trial. Archives of general psychiatry, 1994, Volume: 51, Issue:9 Topics: Adult; Alcohol Drinking; Alcoholism; Anxiety Disorders; Buspirone; Cognitive Behavioral Therapy; Com	1994
Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder. The American journal of psychiatry, 1993, Volume: 150, Issue:4 Topics: Adult; Anxiety Disorders; Buspirone; Depressive Disorder; Double-Blind Method; Drug Therapy, Combina	1993
Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder. The American journal of psychiatry, 1993, Volume: 150, Issue:5 Topics: Adult; Anxiety Disorders; Buspirone; Depressive Disorder; Double-Blind Method; Drug Therapy, Combina	1993
Controlled comparison of the effects and abrupt discontinuation of buspirone and lorazepam. Progress in neuro-psychopharmacology & biological psychiatry, 1995, Volume: 19, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Double-Blind Method; Fem	1995
Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms. The Journal of clinical psychiatry, 1996, Volume: 57, Issue:7 Topics: Adult; Anxiety Disorders; Buspirone; Comorbidity; Depression; Dizziness; Double-Blind Method; Female	1996
Buspirone in the treatment of alcohol dependence: a placebo-controlled trial. Alcoholism, clinical and experimental research, 1996, Volume: 20, Issue:2 Topics: Adult; Alcoholism; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Comorbidity; Double-Blind Meth	1996
Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 11 Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Carbolines; Double-Blind Metho	1997
Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients. Psychopharmacology, 1998, Volume: 136, Issue:4 Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Double-Blind Method; Female; Humans; Loraz	1998
A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder. Psychopharmacology, 1998, Volume: 139, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Depression; Double-Blind	1998
Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:8 Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Buspirone; Cyclohexano	1999
Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention. The American journal of psychiatry, 2000, Volume: 157, Issue:2 Topics: Adult; Amantadine; Anxiety Disorders; Buspirone; Depressive Disorder; Dopamine Agents; Female; Fluox	2000
Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder. The Journal of clinical psychiatry, 2000, Volume: 61, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinica	2000
Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy. The American journal of psychiatry, 2000, Volume: 157, Issue:12 Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepin	2000
Does pretreatment anxiety predict response to either bupropion SR or sertraline? Journal of affective disorders, 2001, Volume: 64, Issue:1 Topics: Antidepressive Agents; Anxiety Disorders; Buspirone; Delayed-Action Preparations; Double-Blind Metho	2001
Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adults. Journal of clinical pharmacology, 2001, Volume: 41, Issue:12 Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Area Under Curve; Buspirone; Child; Elect	2001
Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:11 Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Cyclohexanols; Delayed-Action Preparations; Drug	2001
A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcoholism, clinical and experimental research, 1992, Volume: 16, Issue:6 Topics: Adult; Aftercare; Aged; Alcohol Drinking; Alcoholism; Anxiety Disorders; Buspirone; Dose-Response Re	1992
Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms. A meta-analysis of eight randomized, controlled studies. Neuropsychobiology, 1992, Volume: 25, Issue:4 Topics: Adolescent; Adult; Aged; Anxiety Disorders; Arousal; Buspirone; Depressive Disorder; Female; Humans;	1992
Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). Journal of clinical psychopharmacology, 1992, Volume: 12, Issue:1 Topics: Adult; Alcoholism; Analysis of Variance; Anxiety Disorders; Buspirone; Double-Blind Method; Female;	1992
Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients. Journal of clinical psychopharmacology, 1992, Volume: 12, Issue:2 Topics: Adolescent; Adult; Affect; Anxiety Disorders; Arousal; Attention; Automobile Driver Examination; Aut	1992
Buspirone and related compounds as alternative anxiolytics. Neuropeptides, 1991, Volume: 19 Suppl Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Binding Sites; Buspirone; Humans;	1991
Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder. Psychopharmacology, 1991, Volume: 105, Issue:3 Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Buspirone; Double-Blind Method; Female; Huma	1991
The association of buspirone and its metabolite 1-pyrimidinylpiperazine in the remission of comorbid anxiety with depressive features and alcohol dependency. Psychopharmacology bulletin, 1991, Volume: 27, Issue:2 Topics: Alcoholism; Anxiety Disorders; Buspirone; Depressive Disorder; Double-Blind Method; Humans	1991
A double-blind comparison of buspirone, clobazam, and placebo in patients with anxiety treated in a general practice setting. Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:3 Suppl Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Arousal; Benzodiazepines; Benzodiazepinones; Buspiron	1990
Symptom comorbidity in anxiety and depressive disorders. Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:3 Suppl Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Depressive Disorder; Double-Blind Method;	1990
Buspirone in major depression: a controlled study. The Journal of clinical psychiatry, 1991, Volume: 52, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anxiety Disorders; Buspirone; Depressiv	1991
Buspirone treatment of aggression and anxiety in mentally retarded patients: a multiple-baseline, placebo lead-in study. The Journal of clinical psychiatry, 1991, Volume: 52, Issue:4 Topics: Adult; Aggression; Anxiety Disorders; Buspirone; Dose-Response Relationship, Drug; Female; Humans; I	1991
The assessment and treatment of performance anxiety in musicians. The American journal of psychiatry, 1991, Volume: 148, Issue:5 Topics: Adult; Anxiety Disorders; Buspirone; Cognitive Behavioral Therapy; Combined Modality Therapy; Double	1991
Buspirone therapy for elderly patients with anxiety or depressive neurosis. The Journal of clinical psychiatry, 1990, Volume: 51, Issue:7 Topics: Age Factors; Aged; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Depressive Disorder; Huma	1990
Buspirone therapy in anxious elderly patients: a controlled clinical trial. Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:3 Suppl Topics: Aged; Anxiety Disorders; Buspirone; Depressive Disorder; Female; Humans; Male; Personality Tests; Ra	1990
Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone. The Journal of clinical psychiatry, 1990, Volume: 51 Suppl Topics: Ambulatory Care; Anxiety Disorders; Buspirone; Double-Blind Method; Female; Humans; Lorazepam; Male;	1990
A double-blind, controlled trial in primary care patients with generalized anxiety: a comparison between buspirone and oxazepam. The Journal of clinical psychiatry, 1990, Volume: 51 Suppl Topics: Adolescent; Adult; Aged; Anxiety Disorders; Buspirone; Double-Blind Method; Drug Administration Sche	1990
Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy. The Journal of clinical psychiatry, 1990, Volume: 51 Suppl Topics: Adolescent; Adult; Aged; Alprazolam; Anxiety Disorders; Buspirone; Double-Blind Method; Drug Adminis	1990
Buspirone in the management of major depression: a placebo-controlled comparison. The Journal of clinical psychiatry, 1990, Volume: 51 Suppl Topics: Adolescent; Adult; Aged; Anxiety Disorders; Buspirone; Depressive Disorder; Double-Blind Method; Fem	1990
Buspirone in depressed outpatients: a controlled study. Psychopharmacology bulletin, 1990, Volume: 26, Issue:2 Topics: Anxiety Disorders; Buspirone; Depressive Disorder; Double-Blind Method; Humans; Psychiatric Status R	1990
Long-term buspirone therapy for chronic anxiety: a multicenter international study to determine safety. Southern medical journal, 1990, Volume: 83, Issue:2 Topics: Adolescent; Adult; Aged; Anxiety Disorders; Buspirone; Chronic Disease; Drug Administration Schedule	1990
Is buspirone effective for panic disorder? Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:1 Topics: Adult; Agoraphobia; Anxiety Disorders; Arousal; Buspirone; Double-Blind Method; Fear; Female; Follow	1990
Serotonin-1A anxiolytics: an overview. Psychopathology, 1989, Volume: 22 Suppl 1 Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Buspirone; Clinical Trials as Topic; Double-	1989
A pooled, double-blind comparison of the effects of buspirone, diazepam and placebo in women with chronic anxiety. Current medical research and opinion, 1989, Volume: 11, Issue:5 Topics: Adolescent; Adult; Aged; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Diazepam; Double-Bl	1989
Evaluation of buspirone as an antianxiety agent: buspirone and diazepam versus placebo. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1989, Volume: 34, Issue:8 Topics: Adult; Anxiety Disorders; Buspirone; Diazepam; Double-Blind Method; Female; Humans; Male; Multicente	1989
Comparative assessment of efficacy and withdrawal symptoms after 6 and 12 weeks' treatment with diazepam or buspirone. The British journal of psychiatry : the journal of mental science, 1989, Volume: 154 Topics: Adolescent; Adult; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Diazepam; Double-Blind Me	1989
Double-blind comparison of buspirone and clorazepate in anxious outpatients. The American journal of medicine, 1986, Mar-31, Volume: 80, Issue:3B Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Cl	1986
Review of the side-effect profile of buspirone. The American journal of medicine, 1986, Mar-31, Volume: 80, Issue:3B Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as T	1986
Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study. The Journal of clinical psychiatry, 1986, Volume: 47, Issue:8 Topics: Adolescent; Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; C	1986
Assessing the efficacy of antianxiety agents. The American journal of medicine, 1987, May-22, Volume: 82, Issue:5A Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Diazepam; Double-Blind	1987
Alcohol and drug interactions with antianxiety medications. The American journal of medicine, 1987, May-22, Volume: 82, Issue:5A Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Drug I	1987
A comparison of buspirone, diazepam, and placebo in patients with chronic anxiety states. Journal of clinical psychopharmacology, 1987, Volume: 7, Issue:3 Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Chronic Disease; Clinical Trials as Topic;	1987
Comparison of withdrawal of buspirone and diazepam: a placebo controlled study. Progress in neuro-psychopharmacology & biological psychiatry, 1987, Volume: 11, Issue:2-3 Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Diazepam; Female; Humans; Male; Middle Age	1987
Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone. Archives of general psychiatry, 1988, Volume: 45, Issue:5 Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Clorazepate Dipo	1988
A clinical trial of buspirone and diazepam in the treatment of generalized anxiety disorder. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1987, Volume: 32, Issue:5 Topics: Adult; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Diazepam; Double-Blind Method; Female	1987
Buspirone in the long-term treatment of generalized anxiety disorder. The Journal of clinical psychiatry, 1987, Volume: 48 Suppl Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anxiety Disorders; Buspirone; Clinical Trials as Topic;	1987
[Use of buspirone in cardiac neurosis]. Arquivos brasileiros de cardiologia, 1987, Volume: 49, Issue:1 Topics: Adult; Anxiety Disorders; Buspirone; Cardiovascular Diseases; Clinical Trials as Topic; Female; Huma	1987
The relative efficacy of buspirone, imipramine and placebo in panic disorder: a preliminary report. Pharmacology, biochemistry, and behavior, 1988, Volume: 29, Issue:4 Topics: Adult; Anxiety Disorders; Buspirone; Fear; Female; Humans; Imipramine; Male; Panic; Placebos	1988

Article	Year
Buspirone for Comorbid Anxiety in Autism. The primary care companion for CNS disorders, 2023, 03-16, Volume: 25, Issue:2 Topics: Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Autistic Disorder; Buspirone; Comorbidity; Double-B	2023
Buspirone for the Treatment of Generalized Anxiety Disorder in Williams Syndrome: A Case Series. Journal of autism and developmental disorders, 2020, Volume: 50, Issue:2 Topics: Adolescent; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Comorbidity; Female; Humans; Williams	2020
Buspirone for the Treatment of Generalized Anxiety Disorder in Down Syndrome: 3 Cases. Journal of developmental and behavioral pediatrics : JDBP, 2022, 01-01, Volume: 43, Issue:1 Topics: Adolescent; Anxiety; Anxiety Disorders; Buspirone; Comorbidity; Down Syndrome; Humans; Young Adult	2022
Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route. Pharmaceutical nanotechnology, 2018, Volume: 6, Issue:1 Topics: Administration, Intranasal; Animals; Anxiety Disorders; Brain; Buspirone; Chemistry, Pharmaceutical;	2018
Buspirone for the treatment of anxiety-related symptoms in Angelman syndrome: a case series. Psychiatric genetics, 2019, Volume: 29, Issue:2 Topics: Adult; Angelman Syndrome; Anxiety; Anxiety Disorders; Buspirone; Female; Humans; Intellectual Disabi	2019
Is hippocampal theta frequency related to individual and sex differences in anxiety-like behaviour? An analysis in male and female Long-Evans rats. Behavioural brain research, 2019, 05-17, Volume: 364 Topics: Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Buspirone; Female; Hippocampus; Male; Maze	2019
The diagnosis and treatment of generalized anxiety disorder. Deutsches Arzteblatt international, 2013, Volume: 110, Issue:17 Topics: Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Ben	2013
Correspondence (letter to the editor): Numerous competing interests. Deutsches Arzteblatt international, 2013, Volume: 110, Issue:37 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Cognitive	2013
Correspondence (letter to the editor): One-sided publication. Deutsches Arzteblatt international, 2013, Volume: 110, Issue:37 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Cognitive	2013
Correspondence (letter to the editor): Regular muscle activity. Deutsches Arzteblatt international, 2013, Volume: 110, Issue:37 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Cognitive	2013
Correspondence (letter to the editor): Professional and ethical criticism. Deutsches Arzteblatt international, 2013, Volume: 110, Issue:37 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Cognitive	2013
Correspondence (reply): In reply. Deutsches Arzteblatt international, 2013, Volume: 110, Issue:37 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Cognitive	2013
Behavioral anxiolysis without reduction of hippocampal theta frequency after histamine application in the lateral septum of rats. Hippocampus, 2014, Volume: 24, Issue:6 Topics: Anesthetics, Intravenous; Animals; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Disease Models	2014
Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder. International journal of biological macromolecules, 2015, Volume: 81 Topics: Administration, Intranasal; Animals; Anti-Anxiety Agents; Anxiety Disorders; Biological Availability	2015
An improved human anxiety process biomarker: characterization of frequency band, personality and pharmacology. Translational psychiatry, 2015, Dec-15, Volume: 5 Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Biomarkers; Brain; Buspirone; Electroence	2015
Treatment adequacy of anxiety disorders among young adults in Finland. BMC psychiatry, 2016, Mar-15, Volume: 16 Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Buspirone; Female; Finland; Ho	2016
How multiple medication use evolves and the importance of therapeutic trials: the slippery slide. Journal of psychiatric practice, 2008, Volume: 14, Issue:3 Topics: Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Asthma; Broncho	2008
Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety. Journal of neuroscience methods, 2009, May-30, Volume: 180, Issue:1 Topics: Action Potentials; Adrenergic alpha-Antagonists; Amygdala; Animals; Anti-Anxiety Agents; Anxiety Dis	2009
PRX-00023, a selective serotonin 1A receptor agonist, reduces ultrasonic vocalizations in infant rats bred for high infantile anxiety. Pharmacology, biochemistry, and behavior, 2009, Volume: 94, Issue:1 Topics: Aging; Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Anxiety, Separation; Ataxia; Body T	2009
Methylphenidate-induced obsessive-compulsive symptoms in an elderly man. CNS spectrums, 2003, Volume: 8, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Diso	2003
Buspirone attenuates conditioned fear-induced c-Fos expression in the rat hippocampus. Neuroscience letters, 2005, Dec-02, Volume: 389, Issue:2 Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Avoidance Learning; Buspirone; Conditioning, Psycho	2005
Pharmacological evaluation of the stress-induced social avoidance model of anxiety. Brain research bulletin, 2006, Mar-31, Volume: 69, Issue:2 Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Buspirone; Chlordiazepoxide; Diazepam; Disea	2006
Psychopharmacologic treatment of anxiety. The Journal of clinical psychiatry, 1983, Volume: 44, Issue:8 Pt 2 Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety Disorders; Benzodiaz	1983
Anxiety treatment. A commonsense approach. Postgraduate medicine, 1984, Feb-01, Volume: 75, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Dis	1984
Use of animal models: toward anxioselective drugs. Psychopathology, 1984, Volume: 17 Suppl 1 Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Animal; Benzodiazepines; Buspirone; Confl	1984
Medications in emergencies. Psychiatric services (Washington, D.C.), 1995, Volume: 46, Issue:6 Topics: Anxiety Disorders; Buspirone; Depressive Disorder; Emergencies; Humans; Hypnotics and Sedatives; Pyr	1995
Euphoria with buspirone after fluoxetine treatment. The American journal of psychiatry, 1993, Volume: 150, Issue:1 Topics: Aged; Alzheimer Disease; Anxiety Disorders; Buspirone; Euphoria; Female; Fluoxetine; Humans; Male	1993
Buspirone, anxiety, and sleep. The American journal of psychiatry, 1993, Volume: 150, Issue:5 Topics: Anxiety Disorders; Buspirone; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans	1993
Serotonergic mechanisms involved in the exploratory behaviour of mice in a fully automated two-compartment black and white text box. Pharmacology & toxicology, 1995, Volume: 77, Issue:1 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; A	1995
Disappearance of psychosis after buspirone treatment. The American journal of psychiatry, 1996, Volume: 153, Issue:2 Topics: Aged; Antipsychotic Agents; Anxiety Disorders; Buspirone; Female; Humans; Psychomotor Agitation; Psy	1996
I have heard that buspirone regularly affects various blood tests. Is this so? Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:2 Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Female; Growth Hormone; Humans; Hydrocortisone; M	1996
Buspirone for the treatment of anxiety in patients with chronic obstructive airways disease. Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:5 Topics: Aged; Airway Obstruction; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Humans; Spirometry	1996
Buspirone augmentation of a selective serotonin reuptake inhibitor: efficacy in two depressed patients with comorbid anxiety and type I alcohol dependence. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:5 Topics: 1-Naphthylamine; Adult; Alcoholism; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; B	1997
Lethal interaction of clozapine and buspirone? The American journal of psychiatry, 1997, Volume: 154, Issue:10 Topics: Adult; Anxiety Disorders; Buspirone; Clozapine; Drug Interactions; Drug Therapy, Combination; Gastro	1997
Buspirone treatment of anxiety associated with pharyngeal dysphagia in a four-year-old. Journal of child and adolescent psychopharmacology, 1997,Summer, Volume: 7, Issue:2 Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Child, Preschool; Deglutition Disorders; Humans;	1997
Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone. Psychopharmacology, 1998, Volume: 138, Issue:1 Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Behavior, Animal; Buspirone; Diazepam; Male; Mice;	1998
Lactose in buspirone. Journal of the American Academy of Child and Adolescent Psychiatry, 1999, Volume: 38, Issue:11 Topics: Adolescent; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Chemistry, Pharmaceutical; Female; Hu	1999
Generalized anxiety disorder in family practice patients. American family physician, 2000, Oct-01, Volume: 62, Issue:7 Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Cyclohexanols; Depression; Diagn	2000
[Anxiety neuroses: diagnosis, treatment]. La Revue du praticien, 2000, Sep-15, Volume: 50, Issue:14 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Diagnosis	2000
Serotonin syndrome. A common but often unrecognized psychiatric condition. Geriatrics, 2001, Volume: 56, Issue:1 Topics: Aged; Anxiety Disorders; Buspirone; Citalopram; Depression; Female; Humans; Selective Serotonin Reup	2001
Is imipramine or buspirone treatment effective in patients wishing to discontinue long-term benzodiazepine use? The Journal of family practice, 2001, Volume: 50, Issue:3 Topics: Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Double-Blind Method	2001
Effect of anxiolytics on blood sugar level in rabbits. Indian journal of experimental biology, 2001, Volume: 39, Issue:4 Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Blood Glucose; Buspirone; Diabetes Complications; D	2001
Which medications should be prescribed to treat generalized anxiety disorder (GAD)?. Journal of psychiatry & neuroscience : JPN, 1999, Volume: 24, Issue:1 Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorde	1999
Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder. The Journal of clinical psychiatry, 2001, Volume: 62, Issue:8 Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Drug Administ	2001
Benzodiazepine discontinuation in generalized anxiety disorder. The American journal of psychiatry, 2002, Volume: 159, Issue:2 Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Humans; Imipramine; Long-Term Ca	2002
Buspirone-associated mental status changes. Journal of the American Academy of Child and Adolescent Psychiatry, 1992, Volume: 31, Issue:6 Topics: Anxiety Disorders; Buspirone; Child; Child Abuse; Child of Impaired Parents; Female; Foster Home Car	1992
Pharmacotherapy of childhood anxiety disorders. Clinical neuropharmacology, 1992, Volume: 15 Suppl 1 Pt A Topics: Adolescent; Anxiety Disorders; Buspirone; Child; Female; Humans; Male; Psychiatric Status Rating Sca	1992
Treatment of generalized anxiety disorder and trichotillomania with buspirone. The American journal of psychiatry, 1992, Volume: 149, Issue:4 Topics: Adult; Anxiety Disorders; Buspirone; Female; Humans; Trichotillomania	1992
"Reverse placebo effects": anticipation/anxiety at the possibility of receiving placebos. The Annals of pharmacotherapy, 1992, Volume: 26, Issue:1 Topics: Anxiety Disorders; Buspirone; Clinical Trials as Topic; Humans; Placebo Effect	1992
Buspirone for anxiety disorders in patients with severe lung disease. Lancet (London, England), 1991, Jul-27, Volume: 338, Issue:8761 Topics: Anxiety Disorders; Buspirone; Humans; Lung Diseases	1991
Buspirone: sedative or stimulant effect? The American journal of psychiatry, 1991, Volume: 148, Issue:9 Topics: Adult; Anxiety Disorders; Buspirone; Circadian Rhythm; Female; Humans; Male; Middle Aged; Placebos;	1991
Buspirone-induced mania. The British journal of psychiatry : the journal of mental science, 1991, Volume: 158 Topics: Adult; Alcoholism; Anxiety Disorders; Bipolar Disorder; Buspirone; Ethanol; Humans; Male	1991
Switching from alprazolam to buspirone. Journal of clinical psychopharmacology, 1991, Volume: 11, Issue:3 Topics: Alprazolam; Anxiety Disorders; Buspirone; Humans; Psychiatric Status Rating Scales; Substance Withdr	1991
Serotonin partial agonists in the treatment of anxiety and depression. Introduction. The Journal of clinical psychiatry, 1990, Volume: 51 Suppl Topics: Anxiety Disorders; Buspirone; Depressive Disorder; Humans	1990
Serotonin partial agonists in the treatment of depression. The Journal of clinical psychiatry, 1990, Volume: 51 Suppl Topics: Anxiety Disorders; Buspirone; Depressive Disorder; Humans	1990
Interaction between fluoxetine and buspirone. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1990, Volume: 35, Issue:8 Topics: Adult; Akathisia, Drug-Induced; Anxiety Disorders; Buspirone; Depressive Disorder; Drug Therapy, Com	1990
Intranasal buspirone. Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:4 Topics: Administration, Intranasal; Adult; Anxiety Disorders; Buspirone; Humans; Male; Schizophrenia; Schizo	1990
Buspirone in drug users with AIDS or AIDS-related complex. Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:3 Suppl Topics: Acquired Immunodeficiency Syndrome; Adjustment Disorders; Adult; AIDS Dementia Complex; AIDS-Related	1990
[New perspectives in the pharmacologic treatment of anxiety]. Revista clinica espanola, 1990, Volume: 186, Issue:7 Topics: Anxiety Disorders; Benzodiazepines; Buspirone; Humans	1990
Can buspirone substitute for benzodiazepines in all anxious patients? NIDA research monograph, 1989, Volume: 95 Topics: Adult; Alcoholism; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Humans; Male;	1989
Buspirone and transvestic fetishism. The Journal of clinical psychiatry, 1989, Volume: 50, Issue:11 Topics: Alprazolam; Anxiety Disorders; Buspirone; Fetishism, Psychiatric; Humans; Male; Paraphilic Disorders	1989
Analysis of individual symptoms in generalized anxiety--a pooled, multistudy, double-blind evaluation of buspirone. Neuropsychobiology, 1989, Volume: 21, Issue:3 Topics: Adult; Aged; Anxiety Disorders; Buspirone; Double-Blind Method; Drug Evaluation; Female; Humans; Int	1989
Comparison of diazepam and buspirone. The British journal of psychiatry : the journal of mental science, 1989, Volume: 155 Topics: Anxiety Disorders; Buspirone; Diazepam; Humans	1989
Modern treatment modalities in anxiety. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1989, Jun-17, Volume: 75, Issue:12 Topics: Anxiety Disorders; Buspirone; Humans	1989
Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons. The Journal of clinical psychiatry, 1989, Volume: 50, Issue:10 Topics: Adjustment Disorders; Adult; Aggression; Anxiety Disorders; Buspirone; Female; Humans; Intellectual	1989
Buspirone: effects on prolactin and growth hormone as a function of drug level in generalized anxiety. Journal of clinical psychopharmacology, 1989, Volume: 9, Issue:5 Topics: Anxiety Disorders; Buspirone; Dose-Response Relationship, Drug; Growth Hormone; Humans; Prolactin	1989
Anxiety: the pharmacological and sociological interface. Proceedings of a symposium. Englefield Green, Surrey, 29 November-1 December, 1984. British journal of clinical practice. Supplement, 1985, Volume: 38 Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Humans; Pyrimidines	1985
Buspirone: its potential role in the treatment of general practice anxiety. British journal of clinical practice. Supplement, 1985, Volume: 38 Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Humans; Pyrimidines	1985
Models of anxiety. British journal of clinical practice. Supplement, 1985, Volume: 38 Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Disease Models, Animal; Humans; Neuropsy	1985
Clinical profile of buspirone. British journal of clinical practice. Supplement, 1985, Volume: 38 Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Humans; Pyrimidines	1985
An interim multicentre report on 677 anxious geriatric out-patients treated with buspirone. The British journal of clinical practice, 1986, Volume: 40, Issue:2 Topics: Aged; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Female; Humans; Male; Middle Aged; Pyrimidi	1986
Buspirone: a non-benzodiazepine for anxiety. The Medical letter on drugs and therapeutics, 1986, Dec-05, Volume: 28, Issue:728 Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Humans; Kinetics; Pyrimidines; Substance-Related	1986
Failure of buspirone to manage benzodiazepine withdrawal. The American journal of psychiatry, 1986, Volume: 143, Issue:12 Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Depressive Disorder; Female; Hum	1986
Clinical studies of "specific" anxiolytics as therapeutic agents. Psychopharmacology series, 1987, Volume: 3 Topics: Agoraphobia; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Humans; Mental Diso	1987
Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder. The Journal of clinical psychiatry, 1987, Volume: 48, Issue:5 Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Female; Humans; Male; Personality Inventor	1987
The effect of buspirone on panic disorder: a case report. Journal of clinical psychopharmacology, 1987, Volume: 7, Issue:2 Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Fear; Humans; Male; Panic; Pyrimidines	1987
Impact of anxiety therapy on patients' quality of life. The American journal of medicine, 1987, May-22, Volume: 82, Issue:5A Topics: Anti-Anxiety Agents; Anxiety Disorders; Automobile Driving; Buspirone; Diazepam; Drug Interactions;	1987
BuSpar is clarified. Ohio medicine : journal of the Ohio State Medical Association, 1987, Volume: 83, Issue:5 Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Humans	1987
A study of buspirone co-presented with antihistamines in 68 anxious ambulatory patients. Journal of clinical psychopharmacology, 1988, Volume: 8, Issue:2 Topics: Adult; Ambulatory Care; Anxiety Disorders; Buspirone; Drug Therapy, Combination; Female; Histamine H	1988
New developments in the treatment of anxiety disorders. Texas medicine, 1988, Volume: 84, Issue:9 Topics: Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone	1988
Angina as a symptom of psychiatric illness. Southern medical journal, 1988, Volume: 81, Issue:11 Topics: Adult; Angina Pectoris; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Cardiac Catheterization;	1988
Buspirone overdose. The Medical journal of Australia, 1989, Jan-02, Volume: 150, Issue:1 Topics: Adult; Anxiety Disorders; Buspirone; Humans; Male	1989
Explorative single-blind study on the sedative and hypnotic effects of buspirone in anxiety patients. Acta psychiatrica Scandinavica, 1989, Volume: 79, Issue:2 Topics: Adult; Anxiety Disorders; Buspirone; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Psy	1989
Use of buspirone in an adolescent with overanxious disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 1988, Volume: 27, Issue:6 Topics: Adolescent; Anxiety Disorders; Buspirone; Humans; Male	1988
The safety and usefulness of buspirone as an anxiolytic drug in elderly versus young patients. Clinical therapeutics, 1988, Volume: 10, Issue:6 Topics: Adult; Age Factors; Aged; Anxiety Disorders; Buspirone; Female; Humans; Male; Middle Aged	1988
Buspirone hydrochloride in the treatment of transvestic fetishism. The Journal of clinical psychiatry, 1988, Volume: 49, Issue:10 Topics: Alcoholism; Anxiety Disorders; Buspirone; Fetishism, Psychiatric; Humans; Male; Middle Aged; Paraphi	1988
Alprazolam plus buspirone in treatment of anxiety. The American journal of psychiatry, 1988, Volume: 145, Issue:3 Topics: Adult; Alprazolam; Ambulatory Care; Anxiety Disorders; Buspirone; Drug Therapy, Combination; Female;	1988
A dose range-finding study of buspirone in geriatric patients with symptoms of anxiety. Journal of clinical psychopharmacology, 1988, Volume: 8, Issue:1 Topics: Age Factors; Aged; Anxiety Disorders; Buspirone; Dose-Response Relationship, Drug; Female; Humans; M	1988
Buspirone-induced jitteriness in three patients with panic disorder and one patient with generalized anxiety disorder. The Journal of clinical psychiatry, 1988, Volume: 49, Issue:4 Topics: Adult; Akathisia, Drug-Induced; Anxiety Disorders; Buspirone; Fear; Female; Humans; Male; Panic; Spe	1988
A study of buspirone coprescribed with histamine H2-receptor antagonists in anxious outpatients. International clinical psychopharmacology, 1988, Volume: 3, Issue:1 Topics: Anxiety Disorders; Buspirone; Cimetidine; Drug Therapy, Combination; Female; Humans; Male; Middle Ag	1988
Acute generalized myoclonus following buspirone administration. The Journal of clinical psychiatry, 1988, Volume: 49, Issue:6 Topics: Acute Disease; Akathisia, Drug-Induced; Anxiety Disorders; Buspirone; Clonazepam; Depressive Disorde	1988
Neuroendocrine effects of buspirone in patients with generalized anxiety disorder. The American journal of medicine, 1986, Mar-31, Volume: 80, Issue:3B Topics: Administration, Oral; Adolescent; Adult; Aged; Anxiety Disorders; Buspirone; Drug Evaluation; Female	1986

buspirone and Anxiety Neuroses

Research Excerpts

Research

Studies (241)

Authors

Clinical Trials (2)

Trial Overview

Reviews

Trials

Other Studies

Authors	Studies
Gupta, M	1
Gupta, N	2
Moll, J	1
Ramar, D	1
Thom, RP	2
Keary, CJ	2
Waxler, JL	1
Pober, BR	1
McDougle, CJ	4
Howe, YJ	1
Notson, EE	1
Palumbo, ML	2
Strawn, JR	1
Mills, JA	1
Cornwall, GJ	1
Mossman, SA	1
Varney, ST	1
Keeshin, BR	1
Croarkin, PE	1
Mathure, D	1
Madan, JR	1
Gujar, KN	1
Tupsamundre, A	1
Ranpise, HA	1
Dua, K	1
Mula, M	1
Balaj, K	1
Nowinski, L	1
Walsh, B	1
Mullett, J	1
Thibert, RL	1
Ou, C	1
Dringenberg, HC	2
Soutar, CN	1
Shadli, SM	2
High, O	1
Byers, B	1
Gibbs, P	1
Steller, R	1
Glue, P	2
McNaughton, N	2
Wu, Z	1
Chen, J	1
Yuan, C	1
Hong, W	1
Peng, D	1
Zhang, C	1
Cao, L	1
Fang, Y	1
Bandelow, B	2
Boerner J, R	1
Kasper, S	2
Linden, M	2
Wittchen, HU	2
Möller, HJ	2
Schurig, N	1
Egidi, G	1
Hofmeister, M	1
Müller, W	1
Boerner, RJ	2
Chee, SS	1
Menard, JL	1
Dzampaev, AT	1
Suvorova, IA	1
Damulin, IV	1
Ipser, JC	1
Wilson, D	1
Akindipe, TO	1
Sager, C	1
Stein, DJ	1
Bari, NK	1
Fazil, M	1
Hassan, MQ	1
Haider, MR	1
Gaba, B	1
Narang, JK	1
Baboota, S	1
Ali, J	1
Peoples, AR	1
Bushunow, PW	1
Garland, SN	1
Heckler, CE	1
Roscoe, JA	1
Peppone, LL	1
Dudgeon, DJ	1
Kirshner, JJ	1
Banerjee, TK	1
Hopkins, JO	1
Dakhil, SR	1
Flannery, MA	1
Morrow, GR	1
Howland, RH	1
McIntosh, J	1
Kasteenpohja, T	1
Marttunen, M	1
Aalto-Setälä, T	1
Perälä, J	1
Saarni, SI	1
Suvisaari, J	1
Preskorn, SH	1
Pollack, MH	3
Crespi, F	1
Brunelli, SA	1
Aviles, JA	1
Gannon, KS	1
Branscomb, A	1
Shacham, S	1
Mokhber, N	1
Azarpazhooh, MR	1
Khajehdaluee, M	1
Velayati, A	1
Hopwood, M	1
Ravindran, LN	1
Stein, MB	1
Guaiana, G	1
Barbui, C	1
Cipriani, A	1
Reinhold, JA	1
Mandos, LA	2
Rickels, K	21
Lohoff, FW	1
Gale, CK	1
Millichamp, J	1
Sramek, JJ	4
Zarotsky, V	1
Cutler, NR	4
Bond, AJ	2
Wingrove, J	1
Valerie Curran, H	1
Lader, MH	3
Rynn, M	3
Gorman, JM	4
Sommer, H	1
Berger, W	1
Kuhn, U	1
Schmidt, U	1
Mannel, M	1
Serby, M	1
Masand, PS	1
Gupta, S	1
Gale, C	5
Oakley-Browne, M	5
Majercsik, E	1
Haller, J	2
Leveleki, C	2
Baranyi, J	1
Halász, J	1
Rodgers, RJ	1
Snyderman, SH	1
Rynn, MA	1
Bellew, K	1
Goodman, WK	2
Wisłowska-Stanek, A	1
Zienowicz, M	1
Lehner, M	1
Taracha, E	1
Bidziński, A	1
Maciejak, P	1
Skórzewska, A	1
Szyndler, J	1
Płaźnik, A	1
Lee, ST	1
Park, JH	1
Kim, M	1
McGuinness, TM	1
Fogger, SA	1
Sziray, N	1
Levay, G	1
Barsvári, B	1
Soproni, K	1
Mikics, E	1
Chessick, CA	1
Allen, MH	1
Thase, M	1
Batista Miralha da Cunha, AB	1
Kapczinski, FF	1
de Lima, MS	1
dos Santos Souza, JJ	1
Newton, RE	3
Casten, GP	1
Alms, DR	3
Benes, CO	1
Marunycz, JD	2
Feighner, JP	5
Merideth, CH	1
Hendrickson, GA	1
Uhlenhuth, EH	1
Weisman, K	1
Norstad, N	1
Singer, M	1
Stoltz, D	1
Brown, A	1
Danton, J	1
Wheatley, D	1
Gershon, S	2
Altesman, RI	1
Cole, JO	1
Eison, AS	2
Schuckit, MA	2
Eison, MS	3
Riblet, LA	1
Taylor, DP	4
Temple, DL	1
Tyrer, P	2
Owen, R	2
Goldberg, HL	2
Finnerty, R	1
Pies, R	1
Delle Chiaie, R	1
Pancheri, P	1
Casacchia, M	1
Stratta, P	1
Kotzalidis, GD	1
Zibellini, M	1
Steinberg, JR	1
Wise, MG	2
Griffies, WS	1
Fernandez, F	1
Levy, JK	1
Faludi, G	1
Kranzler, HR	3
Burleson, JA	1
Del Boca, FK	1
Babor, TF	1
Korner, P	1
Brown, J	1
Bohn, MJ	1
Schweizer, E	8
Stoudemire, A	2
Moran, MG	1
Sussman, N	2
Popper, CW	1
Jonas, JM	1
Cohon, MS	1
Lebert, F	1
Pasquier, F	1
Goudemand, M	1
Petit, H	1
Leckman, JF	1
Holzer, JC	1
Barr, LC	1
McCance-Katz, E	1
Heninger, GR	1
Price, LH	1
Grady, TA	1
Pigott, TA	1
L'Heureux, F	1
Hill, JL	1
Bernstein, SE	1
Murphy, DL	1
Hvizdos, AJ	2
Seidehamel, RJ	2
Frances, RJ	1
Borg, L	1
Sánchez, C	1
Medrano, J	1
Padierna, JA	1
Bourin, M	1
Malinge, M	1
Cadieux, RJ	1
Lucki, I	1
Tansman, M	1
Suri, A	1
Hornig-Rohan, M	1
Amsterdam, JD	2
Stahl, SM	1
Weisler, RH	1
Schneider, LS	1
Mintzer, JE	1
Brawman-Mintzer, O	1
Shader, RI	1
Malec, E	1
Malec, T	1
Gagné, MA	1
Dongier, M	2
Malec, TS	1
Malec, EA	1
Alderman, CP	1
Frith, PA	1
Ben-Tovim, DI	1
Pecknold, JC	3
Small, GW	1
Yonkers, KA	1
Hales, RE	1
Hilty, DA	1
Sprenger, D	1
Good, MI	1
Hanna, GL	1
Feibusch, EL	1
Albright, KJ	1
Worthington, JJ	1
Manfro, GG	1
Otto, MW	1
Zucker, BG	1
Laakmann, G	1
Schüle, C	1
Lorkowski, G	1
Baghai, T	1
Kuhn, K	1
Ehrentraut, S	1
Griebel, G	1
Perrault, G	1
Sanger, DJ	1
Lader, M	5
Scotto, JC	1
Apter, JT	1
Allen, LA	1
Hong, WW	1
Hamid, S	1
Nape, B	1
Davidson, JR	2
DuPont, RL	1
Hedges, D	1
Haskins, JT	1
Pao, M	1
Ninan, PT	1
Sheehan, DV	3
Michelson, D	1
Bancroft, J	1
Targum, S	1
Kim, Y	1
Tepner, R	1
DeMartinis, N	2
Mandos, L	1
Magill, MK	1
Gunning, K	1
Rivet, B	1
Roche, F	1
García-España, F	1
Greenblatt, DJ	1
Lantz, MS	1
Sontheimer, DL	1
Ables, AZ	1
Rush, AJ	1
Batey, SR	1
Donahue, RM	1
Ascher, JA	1
Carmody, TJ	1
Metz, A	2
Doraiswamy, PM	1
Dixit, RK	1
Puri, JN	1
Sharma, MK	1
Jain, IP	1
Singh, S	1
Ansari, NA	1
Singh, SP	1
Reesal, RT	1
Arató, M	1
Ballenger, JC	1
Salazar, DE	1
Frackiewicz, EJ	1
Dockens, R	1
Kollia, G	1
Fulmor, IE	1
Tigel, PD	1
Uderman, HD	1
Shiovitz, TM	1
Meoni, P	1
Salinas, E	1
Brault, Y	1
Hackett, D	1
Gupta, R	1
Avasthi, A	1
Malcolm, R	1
Anton, RF	1
Randall, CL	1
Johnston, A	1
Brady, K	1
Thevos, A	1
Soni, P	1
Weintraub, AL	1
Gammans, RE	5
Stringfellow, JC	1
Cohn, JB	6
Wilcox, CS	3
Fabre, LF	2
Smith, WT	1
Simeon, JG	1
Knott, VJ	1
Thatte, S	1
Dubois, CD	1
Wiggins, DM	1
Geraets, I	1
Tollefson, GD	5
Montague-Clouse, J	3
Tollefson, SL	1
Reid, TL	1
van Laar, MW	1
Volkerts, ER	1
van Willigenburg, AP	1
Okada, F	1
Craven, J	1
Sutherland, A	1
Moon, SL	1
Enkelmann, R	1
Napoliello, MJ	6
Domantay, AG	1
Manfredi, RL	1
Kales, A	1
Vgontzas, AN	1
Bixler, EO	1
Isaac, MA	1
Falcone, CM	1
Lancaster, SP	1
Dubovsky, SL	1
Papp, LA	1
Böhm, C	3
Placchi, M	2
Stallone, F	1
Shrotriya, RC	2
Robinson, DS	4
Copp, JE	1
Schwiderski, UE	1
Clary, C	2
Puzzuoli, G	2
McIvor, R	1
Sinanan, K	1
Ratey, J	1
Sovner, R	2
Parks, A	1
Rogentine, K	1
Clark, DB	1
Agras, WS	1
Bystritsky, A	1
Pasnau, RO	1
Leroy, A	1
Dudley, RG	1
Petracca, A	1
Nisita, C	1
McNair, D	1
Melis, G	1
Guerani, G	1
Cassano, GB	1
Strand, M	1
Hetta, J	1
Rosen, A	1
Sörensen, S	1
Malmström, R	1
Fabian, C	1
Marits, K	1
Vetterskog, K	1
Liljestrand, AG	1
Hegen, C	1
Udelman, HD	1
Udelman, DL	1
Dimitriou, E	1
Coplan, JD	1
Amsterdam, J	1
Hassman, J	1
London, J	1
Cummins, TK	1
Diamond, RJ	1
Batki, SL	1
Rodríguez, N	1
Rakel, RE	1
Raj, AB	2
Sheehan, KH	2
Soto, S	2
Boyer, WF	1
Wang, RI	1
Tiuseco, D	1
Roh, BL	1
Cho, JK	1
Kochar, C	1
Fishbain, DA	1
Oswald, I	1
Kahn, RS	1
Cahn, W	1
van Praag, HM	1
Matas, M	2
Howarth, BG	1
Ross, C	1
Swinson, R	1
Vezeau, C	1
Ungar, W	1
Murphy, SM	1
Ratey, JJ	1
Mikkelsen, E	1
Chmielinski, HE	1
Teicher, MH	1
Hoehn-Saric, R	1
McLeod, DR	1
Beaumont, G	1
File, SE	1
Knapp, JE	1
Bowden, CL	2
Fisher, JG	1
Rodos, JJ	1
Alderdice, MT	1
Othmer, E	1
Othmer, SC	1
Frazer, GA	1
Lapierre, YD	1
Rakel, R	1
Olajide, D	1
Fontaine, R	1
Beaudry, P	1
Beauclair, L	1
Chouinard, G	1
Csanalosi, I	1
Case, WG	1
Chung, H	1
Miller, AL	1
Seleshi, E	1
Kane, FJ	1
Harper, RG	1
Wittels, E	1
Tiller, JW	1
Burrows, GD	1
O'Sullivan, BT	1
De Roeck, J	1
Cluydts, R	1
Schotte, C	1
Rouckhout, D	1
Cosyns, P	1
Robinson, D	1
Schenk, J	1
Fedoroff, JP	1
Ross, CA	1
da Cunha, GP	1
de Camargo, MI	1
Singh, AN	1
Beer, M	1
Liegghio, NE	1
Yeragani, VK	1
Moore, NC	1
Levine, S	1
Ritchie, EC	1
Bridenbaugh, RH	1
Jabbari, B	1
Mayol, RF	1
LaBudde, JA	1
Meltzer, HY	1